Fructose metabolic heterogeneity drives vancomycin tolerance in clonal Staphylococcus aureus biofilms
Abstract
Bacterial biofilms are characterized by profound heterogeneity, which is a primary driver of their antibiotic recalcitrance and a major obstacle to clinical infection control. However, how metabolic heterogeneity underpins collective antibiotic tolerance within biofilms remains poorly understood, particularly at single-cell resolution. Here, we apply single-cell RNA sequencing to dissect the response of Staphylococcus aureus ATCC 12600 biofilms to vancomycin. We show that vancomycin induces heterogeneous upregulation of the fructose metabolism genes fruA and fruK, which spatially segregates the biofilm into metabolically active and metabolically reduced subpopulations. Active cells exhibit increased fructose consumption, which fuels peptidoglycan biosynthesis and promotes cell-wall thickening, as a mechanism that directly enhances vancomycin tolerance. In contrast, certain metabolically reduced subpopulations potentiate oxidative stress repair programs, representing an alternative survival strategy. In a diabetic mouse model characterized by impaired fructose clearance, elevated systemic fructose levels exacerbate pulmonary S. aureus infection, indicating that fructose utilization may reflect clinically relevant features of host susceptibility. Together, our findings uncover a fundamental link between metabolic heterogeneity and antibiotic tolerance in S. aureus biofilms, opening new avenues for the rational design of anti-biofilm therapeutics.
Related
- Dietary Fructose Intake, Metabolic Profile, and Liver Disease-Related Quality of Life in Adults with Obesity and MASLD: A Cross-Sectional Study
- Lactiplantibacillus plantarum-Fermented Broccoli Attenuates Metabolic Dysfunction and Improves Skeletal Muscle Quality in High-Fat/High-Fructose Diet-Fed Mice.
- A helminth-microbiota metabolic relay promotes disease tolerance.
- Divergent evolutionary paths of vancomycin resistance operons reveal the transition from mobility to genomic stabilization in Enterococcus faecium
- Genomic features and instability of linezolid resistance in vancomycin-resistant Enterococcus faecalis ST525
BibTeX
@article{jiang2026fructose,
title = {{Fructose metabolic heterogeneity drives vancomycin tolerance in clonal Staphylococcus aureus biofilms}},
author = {Zhichen Jiang and Yuejie Bian and Wei Ding and Liangliang Kong and Xi Yu and Jiejie Hao and Weipeng Zhang},
journal = {The ISME Journal},
year = {2026},
month = oct,
doi = {10.1093/ismejo/wrag265},
url = {https://doi.org/10.1093/ismejo/wrag265},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Fructose metabolic heterogeneity drives vancomycin tolerance in clonal Staphylococcus aureus biofilms
AU - Zhichen Jiang
AU - Yuejie Bian
AU - Wei Ding
AU - Liangliang Kong
AU - Xi Yu
AU - Jiejie Hao
AU - Weipeng Zhang
PY - 2026
DA - 2026/10/13
JO - The ISME Journal
DO - 10.1093/ismejo/wrag265
UR - https://doi.org/10.1093/ismejo/wrag265
AB - Bacterial biofilms are characterized by profound heterogeneity, which is a primary driver of their antibiotic recalcitrance and a major obstacle to clinical infection control. However, how metabolic heterogeneity underpins collective antibiotic tolerance within biofilms remains poorly understood, particularly at single-cell resolution. Here, we apply single-cell RNA sequencing to dissect the response of Staphylococcus aureus ATCC 12600 biofilms to vancomycin. We show that vancomycin induces heterogeneous upregulation of the fructose metabolism genes fruA and fruK, which spatially segregates the biofilm into metabolically active and metabolically reduced subpopulations. Active cells exhibit increased fructose consumption, which fuels peptidoglycan biosynthesis and promotes cell-wall thickening, as a mechanism that directly enhances vancomycin tolerance. In contrast, certain metabolically reduced subpopulations potentiate oxidative stress repair programs, representing an alternative survival strategy. In a diabetic mouse model characterized by impaired fructose clearance, elevated systemic fructose levels exacerbate pulmonary S. aureus infection, indicating that fructose utilization may reflect clinically relevant features of host susceptibility. Together, our findings uncover a fundamental link between metabolic heterogeneity and antibiotic tolerance in S. aureus biofilms, opening new avenues for the rational design of anti-biofilm therapeutics.
SN - 1751-7362
SN - 1751-7370
ER -